Episodes

Experts have been ringing the alarm about the impending healthcare delivery professional workforce shortage for over a decade. Mindy & Ryan are joined by Vynamic’s Marisa Deline to explore the broad implications of this shortage and discuss ways healthcare leaders across sectors can think about addressing - or simply learning to live with - this foundational issue. The conversation begins with a detailed overview of the widespread nature of the shortage: from physicians to medical assistants the...

Experts have been ringing the alarm about the impending healthcare delivery professional workforce shortage for over a decade. Mindy & Ryan are joined by Vynamic’s Marisa Deline to explore the broad implications of this shortage and discuss ways healthcare leaders across sectors can think about addressing - or simply learning to live with - this foundational issue. The conversation begins with a detailed overview of the widespread nature of the shortage: from physicians to medical assistants the...

In this minisode, Mindy and Ryan examine a few recent newsworthy items including trends impacting digital health funding (0:48), the newly operational 988 mental health and suicide crisis line (4:00), the latest impacts on the healthcare industry post Roe v. Wade (6:45), and discussions regarding the future of the 340B prescription drug program (13:49). Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, mental health, maternal ...

In this minisode, Mindy and Ryan examine a few recent newsworthy items including trends impacting digital health funding (0:48), the newly operational 988 mental health and suicide crisis line (4:00), the latest impacts on the healthcare industry post Roe v. Wade (6:45), and discussions regarding the future of the 340B prescription drug program (13:49). Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, mental health, maternal ...

In this minisode, Mindy and Ryan examine a few recent newsworthy items including trends impacting digital health funding (0:48), the newly operational 988 mental health and suicide crisis line (4:00), the latest impacts on the healthcare industry post Roe v. Wade (6:45), and discussions regarding the future of the 340B prescription drug program (13:49). Podcast Tags: healthcare, healthcare news, women’s health, reproductive health, public health, providers, Roe v. Wade, mental health, maternal ...

On Trending Health’s second Trending News EU episode, Mindy, Jack, and Oliver discuss a few recent EU-based newsworthy items including: the outcome of the NHS Pay Review Body process, which advises on the pay for NHS staff (0.37), worrying General Practitioner (GP) workforce challenges amid unprecedented staff shortages (4.44), and the rise of Public Health infectious disease incidents and possible solutions to address (9.18). Podcast Tags: healthcare, healthcare news, NHS, NHSPRB, clinician bu...

On Trending Health’s second Trending News EU episode, Mindy, Jack, and Oliver discuss a few recent EU-based newsworthy items including: the outcome of the NHS Pay Review Body process, which advises on the pay for NHS staff (0.37), worrying General Practitioner (GP) workforce challenges amid unprecedented staff shortages (4.44), and the rise of Public Health infectious disease incidents and possible solutions to address (9.18). Podcast Tags: healthcare, healthcare news, NHS, NHSPRB, clinician bu...

On Trending Health’s second Trending News EU episode, Mindy, Jack, and Oliver discuss a few recent EU-based newsworthy items including: the outcome of the NHS Pay Review Body process, which advises on the pay for NHS staff (0.37), worrying General Practitioner (GP) workforce challenges amid unprecedented staff shortages (4.44), and the rise of Public Health infectious disease incidents and possible solutions to address (9.18). Podcast Tags: healthcare, healthcare news, NHS, NHSPRB, clinician bu...

Now more than ever, launching new biopharmaceutical products or indications is of paramount importance to ensuring its long-term success in the market. Mindy & Jen are joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, to discuss the evolution of the importance of product launch and the implications for Life Sciences organizations and the healthcare industry at large. The catalyzing force shaping the launch space over the past several years is the sheer volume of t...

Now more than ever, launching new biopharmaceutical products or indications is of paramount importance to ensuring its long-term success in the market. Mindy & Jen are joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, to discuss the evolution of the importance of product launch and the implications for Life Sciences organizations and the healthcare industry at large. The catalyzing force shaping the launch space over the past several years is the sheer volume of t...

Now more than ever, launching new biopharmaceutical products or indications is of paramount importance to ensuring its long-term success in the market. Mindy & Jen are joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, to discuss the evolution of the importance of product launch and the implications for Life Sciences organizations and the healthcare industry at large. The catalyzing force shaping the launch space over the past several years is the sheer volume of t...

In our typical Trending News US episodes, we examine a few recent newsworthy items we think healthcare leaders should be considering. For today’s episode, we focus on the Supreme Court’s ruling on Dobbs v. Jackson, a case centered on a Mississippi law that bars most abortions after 15 weeks of pregnancy, a standard that directly challenged Roe v. Wade. On Friday June 24th, in one of the most consequential decisions in decades, the Court ruled in favor of overturning Roe – holding there is no lon...

In our typical Trending News US episodes, we examine a few recent newsworthy items we think healthcare leaders should be considering. For today’s episode, we focus on the Supreme Court’s ruling on Dobbs v. Jackson, a case centered on a Mississippi law that bars most abortions after 15 weeks of pregnancy, a standard that directly challenged Roe v. Wade. On Friday June 24th, in one of the most consequential decisions in decades, the Court ruled in favor of overturning Roe – holding there is no lon...

In our typical Trending News US episodes, we examine a few recent newsworthy items we think healthcare leaders should be considering. For today’s episode, we focus on the Supreme Court’s ruling on Dobbs v. Jackson, a case centered on a Mississippi law that bars most abortions after 15 weeks of pregnancy, a standard that directly challenged Roe v. Wade. On Friday June 24th, in one of the most consequential decisions in decades, the Court ruled in favor of overturning Roe – holding there is no lon...

In Trending Health’s first Trending News EU episode, Mindy, Jack and Oliver discuss a few recent EU-based newsworthy items including: an unprecedented clinical trial where a dozen rectal cancer patients saw their tumors completely disappear (1:12), the Health & Care Act 2022 which is seen as the most significant health legislation in the UK in a decade (3:56) and a report that showed up to 1.2 million additional NHS patients are eligible for vital medicines that could extend their lives but are ...

In Trending Health’s first Trending News EU episode, Mindy, Jack and Oliver discuss a few recent EU-based newsworthy items including: an unprecedented clinical trial where a dozen rectal cancer patients saw their tumors completely disappear (1:12), the Health & Care Act 2022 which is seen as the most significant health legislation in the UK in a decade (3:56) and a report that showed up to 1.2 million additional NHS patients are eligible for vital medicines that could extend their lives but are ...

In Trending Health’s first Trending News EU episode, Mindy, Jack and Oliver discuss a few recent EU-based newsworthy items including: an unprecedented clinical trial where a dozen rectal cancer patients saw their tumors completely disappear (1:12), the Health & Care Act 2022 which is seen as the most significant health legislation in the UK in a decade (3:56) and a report that showed up to 1.2 million additional NHS patients are eligible for vital medicines that could extend their lives but are ...

As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate s...

As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate s...

As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate s...

As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate s...

As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate s...

As health systems around the globe grapple with addressing inequity in healthcare, one of the most tangible opportunities for change is the chronic underrepresentation of individuals by race, ethnicity, or sex in clinical trials. Jen & Ryan are joined by Vynamic’s Matt Howard to discuss how life science companies can integrate diversity, equity & inclusion throughout the clinical trials process to facilitate better outcomes. Better representation across patient types is critical to demonstrate s...

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the nationwide baby formula shortage and drug supply chain complexities (00:33), the underrepresentation of diverse groups in clinical trials (06:08), and the federal government probes initiated by the AHA into commercial payers who represent Medicare and routinely deny access to care and services (10:52). Podcast Tags: healthcare, healthcare news, life sciences, baby formula shortage, drug supply chain, cli...